Tubulointerstitial biomarkers for diabetic nephropathy
B Satirapoj - Journal of diabetes research, 2018 - Wiley Online Library
Patients with diabetic nephropathy have a higher risk of mortality, mostly from cardiovascular
complications. Standard biomarkers including serum creatinine, estimated glomerular …
complications. Standard biomarkers including serum creatinine, estimated glomerular …
Role of MCP-1 as an inflammatory biomarker in nephropathy
Y Liu, K Xu, Y Xiang, B Ma, H Li, Y Li, Y Shi… - Frontiers in …, 2024 - frontiersin.org
The Monocyte chemoattractant protein-1 (MCP-1), also referred to as chemokine ligand 2
(CCL2), belongs to the extensive chemokine family and serves as a crucial mediator of …
(CCL2), belongs to the extensive chemokine family and serves as a crucial mediator of …
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—An open-label pilot study
Background Improvement of proteinuria as a marker for disease activity is associated with a
better renal outcome in immunoglobulin A nephropathy (IgAN). Complement is an effector …
better renal outcome in immunoglobulin A nephropathy (IgAN). Complement is an effector …
[HTML][HTML] Urinary exosomes and exosomal CCL2 mRNA as biomarkers of active histologic injury in IgA nephropathy
IgA nephropathy (IgAN) features variable renal pathology and a heterogeneous clinical
course. Our aim was to search noninvasive biomarkers from urinary exosomes for IgAN …
course. Our aim was to search noninvasive biomarkers from urinary exosomes for IgAN …
Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic …
B Satirapoj, R Dispan, P Radinahamed, C Kitiyakara - BMC nephrology, 2018 - Springer
Background Increased monocyte chemoattractant protein-1 (MCP-1) and decreased
epidermal growth factor (EGF) are promising biomarkers to predict progressive decline in …
epidermal growth factor (EGF) are promising biomarkers to predict progressive decline in …
[HTML][HTML] Urinary EGF and MCP-1 and risk of CKD after cardiac surgery
S Menez, W Ju, R Menon, DG Moledina, HT Philbrook… - Jci Insight, 2021 - ncbi.nlm.nih.gov
BACKGROUND Assessment of chronic kidney disease (CKD) risk after acute kidney injury
(AKI) is based on limited markers primarily reflecting glomerular function. We evaluated …
(AKI) is based on limited markers primarily reflecting glomerular function. We evaluated …
[HTML][HTML] Factores de riesgo de Nefropatía Diabética
A Villena Pacheco - Acta Médica Peruana, 2021 - scielo.org.pe
La nefropatía diabética (ND) es un problema de salud pública cuya prevalencia se
encuentra en continuo incremento, representa una importante carga económica, social y de …
encuentra en continuo incremento, representa una importante carga económica, social y de …
[HTML][HTML] The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events
Biomarkers of tubular function such as epidermal growth factor (EGF) may improve
prognostication of participants at highest risk for chronic kidney disease (CKD) after …
prognostication of participants at highest risk for chronic kidney disease (CKD) after …
Urinary epidermal growth factor: a promising “next generation” biomarker in kidney disease
C Cortvrindt, R Speeckaert, JR Delanghe… - American journal of …, 2022 - karger.com
Background: The epidermal growth factor (EGF) is a globular protein that is generated in the
kidney, especially in the loop of Henle and the distal convoluted tubule. While EGF is …
kidney, especially in the loop of Henle and the distal convoluted tubule. While EGF is …
Novel mechanism of the pericyte-myofibroblast transition in renal interstitial fibrosis: core fucosylation regulation
N Wang, Y Deng, A Liu, N Shen, W Wang, X Du… - Scientific reports, 2017 - nature.com
Pericytes have been identified as a major source of myofibroblasts in renal interstitial fibrosis
(RIF). The overactivation of several signaling pathways, mainly the TGF-β and PDGF …
(RIF). The overactivation of several signaling pathways, mainly the TGF-β and PDGF …